Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children
NCT05240456
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Voiding Disorders
Overactive Bladder
Interventions
DRUG:
Beta3-Agonists, Adrenergic
DRUG:
Anticholinergic drug, Solifenacin
Sponsor
Mansoura University